Yahoo Finance 
Transdermal Skin Patches Global Market Report to 2032: Players Include Mylan Pharmaceuticals, Hisamitsu Pharmaceutical, Novartis, Teikoku Pharma and Actavis
Global Transdermal Skin Patches Market
Dublin, March 16, 2023 (GLOBE NEWSWIRE) -- The "Transdermal Skin Patches Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
This report provides strategists, marketers and senior management with the critical information they need to assess the market.
The global transdermal skin patches market is expected to grow from $6.80 billion in 2021 to $7.10 billion in 2022 at a compound annual growth rate (CAGR) of 4.5%. The transdermal skin patches market is expected to reach $8.13 billion in 2026 at a CAGR of 3.4%.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Major players in the transdermal skin patches market are Mylan Pharmaceuticals Inc, Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan, Actavis, Mundipharma, Henan Lingrui Pharmaceutical, Changzhou Siyao, Rfl Pharmaceutical, Teva, ProSolus Inc, Medipatch Inc, AdhexPharma, Medherant Limited, Nitto Denko, Noven Pharmaceuticals, 3M Pharmaceuticals, Accrux Ltd, Access Pharmaceuticals Inc, Luye Pharma Group Ltd., Purdue Pharma L.P., Abbott Laboratories, Aneva Drug Delivery Systems, Allergan plc, Corium International Inc., Immune Pharmaceuticals, Hercon Pharmaceuticals, Pocono and DURECT Corporation.
The transdermal skin patches market consists of sales of single-layer drug-in-adhesive, multi-layer drug-in-adhesive, and vapour patch. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
Transdermal skin patches refer to a drug delivery technique where a pre-prescribed dose of medication is applied as an adhesive patch and absorbed via the skin into the bloodstream. They deliver a precise, preset dosage of medication that is absorbed into the bloodstream through the skin.
North America was the largest region in the transdermal skin patches market in 2022. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the transdermal skin patches market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The main types of transdermal skin patches are fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch and others. Nicotine transdermal skin patches are used to assist people in quitting smoking. They provide a source of nicotine through the skin of the human body that helps to alleviate the withdrawal symptoms associated with quitting smoking. The various products used involve matrix, drugs in the adhesive, reservoir, and vapor that are utilized for pain relief, nicotine cessation, hormone replacement therapy, neurological disorders, cardiovascular disorders, and others.
The advances in modern technologies contribute to the growth of the transdermal skin patches market. Advances in modern technologies increase the number of drugs being delivered transdermally including small molecule hydrophobic drugs, hydrophilic drugs, and macromolecules.
The new technological advances add to the increased efficiency and increased use of transdermal drug delivery systems (TDDS) thus, increasing the popularity and demand for TDDS. For instance, in September 2022, Corium, a US-based biopharmaceutical company, launched Adlarity, a transdermal patch for treating Alzheimer's.
It is a donepezil transdermal system that distributes donepezil at regular intervals through the skin. It treats people with Alzheimer's-related dementia that is mild, moderate, or severe. Adlarity makes use of the unique Corplex technology from Corium. Over a predetermined period of time, Corplex provides continuous, controlled, and sustained medication release.
Stringent regulatory approval by the government regulatory bodies is a key factor hindering the growth of the transdermal skin patches market. The regulatory authority enforces the laws regulating biologics, medications, and medical devices, which can have potential side effects for customers.
For instance, Food and Drug Administration (FDA) mandates the TDDS to undergo a series of tests including biomechanical testing, animal testing, and clinical trials before approving the TDDS for use in the market. The whole process consumes time and may result in a delay for the launch of TDDS into the market losing the first-mover advantage thus restraining the growth of the transdermal skin patch market.
Major companies in the market are increasingly opting for acquisitions and collaborations to enhance and expand their footprint for the growth of the transdermal skin patches market. The strategic merger and acquisition and collaboration followed by the players in the transdermal skin patches market allow the companies to take technological advantage by acquiring the technology which allows them to get ahead in the competition.
The countries covered in the transdermal skin patches market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Key Attributes:
Report Attribute | Details |
No. of Pages | 250 |
Forecast Period | 2022 - 2026 |
Estimated Market Value (USD) in 2022 | $7.1 billion |
Forecasted Market Value (USD) by 2026 | $8.13 billion |
Compound Annual Growth Rate | 3.4% |
Regions Covered | Global |
Key Topics Covered:
1. Executive Summary
2. Transdermal Skin Patches Market Characteristics
3. Transdermal Skin Patches Market Trends And Strategies
4. Transdermal Skin Patches Market - Macro Economic Scenario
4.1 COVID-19 Impact On Transdermal Skin Patches Market
4.2 Ukraine-Russia War Impact On Transdermal Skin Patches Market
4.3 Impact Of High Inflation On Transdermal Skin Patches Market
5. Transdermal Skin Patches Market Size And Growth
5.1. Global Transdermal Skin Patches Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Transdermal Skin Patches Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Transdermal Skin Patches Market Segmentation
6.1. Global Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Matrix
Drug In Adhesive
Reservoir
Vapor
6.2. Global Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Other Types
6.3. Global Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Pain Relief
Nicotine Cessation
Hormone Replacement Therapy
Neurological Disorders
Cardiovascular Disorders
Other Applications
7. Transdermal Skin Patches Market Regional And Country Analysis
7.1. Global Transdermal Skin Patches Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Transdermal Skin Patches Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
For more information about this report visit https://www.researchandmarkets.com/r/yjsee2
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
